National Institutes of Health FY2019 National Cancer Institute (NCI) Grant Support in Massachusetts – Congressional District 7

Fiscal Year 2019 National Institutes of Health Funding in Massachusetts as of December 11, 2018. Data Extracted from NIH Reporter.

1 Novel Anti-Cancer Biologics Targeting Wnt Signaling Pathway 1R21CA235533-01 Dong, Min Boston Children’s Hospital $233,051
2 Degrading Therapeutically Important Kinases Using Small Molecules 1R01CA218278-01A1 Gray, Nathanael Schiander Dana-Farber Cancer Institute $650,235
3 Molecular Mechanisms and Therapeutic Targeting of Pi3k-P110beta/PTEN Signaling in Breast Cancer and Cancer Immunity 1R01CA233810-01 Roberts, Thomas M Dana-Farber Cancer Institute $497522
4 Novel Therapeutic Approaches with Cdk4/6 Inhibitors for Melanoma Treatment 1R01CA236226-01 Sicinski, Peter Dana-Farber Cancer Institute $477643
5 RNA-Binding Proteins as Molecular Integrators That Control the Response of HGSOC to Anti-Cancer Therapies 1R01CA226898-01A1 Yaffe, Michael B Massachusetts Institute of Technology $536497
6 Transforming Mechanisms of Merkel Cell Polyoma Virus 2R01CA173023-06A1 Decaprio, James A Dana-Farber Cancer Institute $419188
7 Targeting Alk Through Degradation and Allosteric Inhibitors 2R01CA136851-10 Gray, Nathanael Schiander Dana-Farber Cancer Institute $373272
8 Evaluating Mass Spectrometry for Intraoperative Tissue Characterization In Breast-Conserving Therapy 5R01CA201469-04 Agar, Nathalie Brigham and Women’s Hospital $393,849
9 Personalized Vaccine for Patients with AML 5R01CA212649-03 Avigan, David E Beth Israel Deaconess Medical Center $699,542
10 Usp7 Inhibitors for the Treatment of Multiple Myeloma 5R01CA211681-03 Buhrlage, Sara J Dana-Farber Cancer Institute $510,712
11 Development of Molecular Probes to Investigate and Drug the Oncogenic Wnt/?-Catenin/Bcl9/B9l Transcriptional Complex 5R21CA221683-02 Carrasco, Ruben D Dana-Farber Cancer Institute $185,134
12 Apobec Proteins As Drivers of Chromosomal Translocations In Solid Cancers 5R01CA222598-02 Chiarle, Roberto Boston Children’s Hospital $392,740
13 Elucidating the Regulation and Function of the NF1 Tumor Suppressor 5R01CA111754-14 Cichowski, Karen M Brigham and Women’s Hospital $307,135
14 Molecular Connections Among UV Exposure; Red Hair; Nevi and Melanoma 5R01CA193913-04 Cui, Rutao Boston University Medical Campus $366,114
15 Discovery and Optimization of Novel Mutant-Selective Allosteric Inhibitors of EGFR T790m 5R01CA201049-04 Eck, Michael J Dana-Farber Cancer Institute $453,318
16 Development of Diagnostic and Prognostic Tests for Esophageal Adenocarcinoma 5R01CA208599-03 Godfrey, Tony E BOSTON UNIVERSITY MEDICAL CAMPUS $428,383
17 Regulation of the LIN28/LET-7 Pathway In Cancer 5R01CA211328-03 Gregory, Richard I. BOSTON CHILDREN’S HOSPITAL, $392,740
18 How Does Malignancy Subvert Platelet Megakaryocytic Biology? 5R01CA200748-03 Italiano, Joseph E. Brigham and Women’s Hospital $534,417
19 Inhibiting Extracellular Hsp90 to Reduce Breast Cancer Metastasis 5R01CA183119-04 Jay, Daniel G. TUFTS UNIVERSITY BOSTON $366,114
20 Mir-199~214 Cluster at the Crossroads of Plasticity and Malignancy In Breastcancer 5R01CA207322-03 Karnoub, Antoine Elias Beth Israel Deaconess Medical Center $383,865
21 Interplay of Mammary Luminal Cells and Environmental Factors in Establishing p53-Deficient Premalignant Field 5R01CA222560-02 Li, Zhe Brigham and Women’s Hospital $363,522
22 Polyploidy; Aneuploidy; and Genome Stability 5R01CA213404-21 Pellman, David S Dana-Farber Cancer Institute $388,303
23 Systemic RNA Delivery to Tumors 5R01CA200900-04 Shi, Jinjun Brigham and Women’s Hospital $526,391
24 Lipid-Dendrimer Micellar Nanocarriers for SIRNA/Drug Co-Delivery In MDR Cancer 5R01CA200844-04 Torchilin, Vladimir P Northeastern University $339,188
25 Reprogramming the Tumor Microenvironment via Self-Amplified RNA (Safer) Circuits 5R01CA206218-04 Weiss, Ron Massachusetts Institute of Technology $533,720
26 Dietary Control of Stem Cells in Physiology and Cancer 5R01CA211184-03 Yilmaz, Omer Massachusetts Institute of Technology $397,201
27 Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor 5R01CA211646-03 Zetter, Bruce R. Boston Children’s Hospital $396,856




Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s